Britain Moving Too Fast on 3-Parent Children
By Editorial,
Los Angeles Times
| 03. 11. 2015
Untitled Document
A procedure newly approved in Britain allows babies to be conceived with DNA from three parents — a mix of DNA that would determine the child's characteristics and become part of the gene pool in future generations. Last year, a U.S. Food and Drug Administration advisory panel wisely decided that this procedure, designed to overcome the devastating effects of mitochondrial disease, wasn't ready for human trials, much less therapeutic use. With its premature approval, Britain has opened the way for three-parent children around the world, because anyone with enough money can travel there for the procedure.
Mitochondria are the specialized compartments within cells that are responsible for creating most of the energy needed by the body. But when a mother's mitochondria are faulty, the resulting disorder can be disabling or fatal to her offspring. Children born with mitochondrial disorder might lose muscle control, suffer muscle weakness and pain, have difficulty breathing and be beset by heart and liver problems.
Researchers hope to overcome this by removing the nucleus from the egg of a woman who has the disorder...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...